Kenneth R. Carson

Apr 2, 2024 | ajmc.com | Jason Gibbons |Charles Bennett |Kenneth R. Carson |Gerard F. Anderson

ABSTRACTThe Inflation Reduction Act of 2022 (IRA) allows the Medicare program to negotiate drug prices beginning in 2024. Based on the guidance in the statute, CMS has selected specific data items to use to adjust initial price offers for 10 drugs in the decision-making process. Although much of the data are publicly available, some of these data items will need to be collected directly from drug companies.